← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Thromgen, Inc.
Ann Arbor, MI
$2,289,201
Total funding
4
Grants
Funding over time
peak $877.3K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$2,289,201 · 4
By mechanism
R44$1,603,627 · 2
R42$585,575 · 1
R43$99,999 · 1
Investigators at Thromgen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Thrombostatin-A Thrombin Receptor Inhibitor$877,297
R44 · FY2005 · HL
Thrombostatin-A Thrombin Receptor Inhibitor$606,945
R44 · FY2006 · HL
Thrombostatin In The Folts Model for Coronary Thrombosis$585,575
R42 · FY2001 · HL
PREVENTION OF CORONARY THROMBOSIS BY THROMBOSTATIN$119,385
R44 · FY2000 · HL
Thrombostatin Prevents LPS-Induced Shock$99,999
R43 · FY2001 · GM